Contract for the Supply of Strategic Stockpile of Medicines 2021

Contract for the Supply of Strategic Stockpile of Medicines 2021

Supply of atropine sulfate solution for injection, ciprofloxacin tablets and solution for infusion and Prussian blue (ferric hexacyanoferrate).

United Kingdom-London: Pharmaceutical products

2020/S 111-270678

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Department of Health and Social Care
Postal address: 39 Victoria Street
Town: London
NUTS code: UKI32 Westminster
Postal code: SW1H 0EU
Country: United Kingdom
E-mail: lynne.nichols@dhsc.gov.uk

I.2)Information about joint procurement

The contract is awarded by a central purchasing body

I.3)Communication

Access to the procurement documents is restricted. Further information can be obtained at: https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: https://health-family.force.com/s/Welcome

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Contract for the Supply of Strategic Stockpile of Medicines 2021

Reference number: CM/EMP/15/5473/662

II.1.2)Main CPV code

33600000 Pharmaceutical products

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Procurement exercise for a contract(s) for the supply of atropine sulfate solution for injection, ciprofloxacin tablets and solution for infusion and Prussian blue (ferric hexacyanoferrate).

II.1.5)Estimated total value

Value excluding VAT: 2 500 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description

II.2.1)Title:

Prussian Blue (Ferric Hexacyanoferrate) Capsules 500 mg

Lot No: 6

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of Prussian blue (ferric hexacyanoferrate) capsules 500 mg.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

II.2)Description

II.2.1)Title:

Ciprofloxacin Tablets 250 mg

Lot No: 3

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of ciprofloxacin 250 mg tablets.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

II.2)Description

II.2.1)Title:

Ciprofloxacin Tablets 500 mg

Lot No: 4

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of ciprofloxacin 500 mg tablets.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

II.2)Description

II.2.1)Title:

Ciprofloxacin Intravenous Infusion 400 mg/200 ml

Lot No: 5

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of ciprofloxacin intravenous infusion 400 mg/200 ml.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

II.2)Description

II.2.1)Title:

Ciprofloxacin Tablets 100 mg

Lot No: 2

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of ciprofloxacin 100 mg tablets.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

II.2)Description

II.2.1)Title:

Atropine Sulfate Solution for Injection 3 mg/10 ml Pre-filled Syringe

Lot No: 1

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UKD NORTH WEST (ENGLAND)
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

Procurement exercise for a contract for the provision of Atropine sulfate solution for injection 3 mg/10 ml pre-filled syringe.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/04/2021
End: 31/03/2022
This contract is subject to renewal: no
II.2.9)Information about the limits on the number of candidates to be invited

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Details of the volumes required will be provided to qualified suppliers at ITO stage.

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Restricted procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 14/07/2020
Local time: 13:00

IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 22/07/2020

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about electronic workflows

VI.3)Additional information:

Responding to this notice: suppliers who do not respond to this procurement exercise in the following manner may be disqualified from the procurement process provided that the following conditions will operate in addition to and not replace any other conditions stated in the procurement documents which may result in disqualification.

1) Submission of expression of interest and procurement specific information.

This procurement exercise will be conducted on the eTendering portal at https: //health-family.force.com/s/Welcome Candidates wishing to be considered for this procurement exercise must register and provide additional procurement specific information (if requested), through the eTendering portal as follows

1.1) If not already registered, candidates should register on the eTendering portal at https://health-family.force.com/s/Welcome and click the link to register:

— ‘accept the terms and conditions’;

— enter your correct business details;

— click ‘Submit’ when complete;

— you will shortly receive an email from the Salesforce platform asking you to finalise your registration.

1.2) Once registered, candidates must express interest as follows:

(a) login to the eTendering portal;

(b) select ‘Find Opportunities’;

(c) select the opportunity that you are interested in;

(d) ‘Register interest’;

(e) select ‘confirm’;

(f) once you have expressed interest, it will move to ‘My Proposals and Quotes’, where you can download additional documentation (if required) and construct your reply as instructed.

You must then publish your reply using the ‘Publish’ button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact the Atamis Help-desk at +44 800 9956035 or support-health@atamis.co.uk.

2) General supplier information.

To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, supplier registration, as follows

2.1) If not already registered, candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top right of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S® Number to enable registration on Supplier Registration.

2.2) Once registration is complete you are able to create and update your registered company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning supplier registration, please contact the Helpdesk at: support@nqc.com or telephone +44(0)1614137982. Documentation availability candidates are advised that the contracting authority has taken measures to protect confidential information contained within the full suite of procurement documents by restricting access to those documents. The contracting authority will only provide access to the full suite of procurement documents to candidates who satisfy the selection criteria and complete the non-disclosure agreement provided via Atamis eTendering portal in accordance with the instructions provided by the contracting authority. The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers.

VI.4)Procedures for review

VI.4.1)Review body

Official name: The High Court
Postal address: Strand
Town: London
Postal code: WC2A 2LL
Country: United KingdomInternet address: https://www.gov.uk/courts-tribunals
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

08/06/2020